Appili Therapeutics Inc (APLI : TSX)
Common Stock
$0.01
CAD
+0.00 (%)
Last updated: 2026-07-10
APLI
Appili Therapeutics Inc
WealthAwesomePerformance
1 Day
+0.00%
1 Week
+0.00%
1 Month
+0.00%
YTD
-40.00%
Key Statistics
Market Cap
$1.99M
52W High
$0.04
52W Low
$0.01
P/E Ratio
-
50 Day MA
$0.02
200 Day MA
$0.02
Beta
-0.21
Dividend Yield
-
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 7/10/2026 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | 7,002 |
| 7/9/2026 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | 300,000 |
| 7/7/2026 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | 64,000 |
| 7/3/2026 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | 0 |
| 7/2/2026 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | 58,300 |
| 6/30/2026 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | 25,000 |
| 6/29/2026 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | 37,010 |
| 6/26/2026 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | 0 |
| 6/25/2026 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | 1,000 |
| 6/24/2026 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | 0 |
Analyst Price Targets
Based on analyst covering APLI
Wall Street analysts forecast APLI stock price to rise 900.0% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.15
+900.0% Upside
Current Price
C$0.01
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on APLI's historical volatility
30-Day Vol
146.1%
Annualized
90-Day Vol
206.5%
Annualized
Trend (90d)
+0.0%
Annualized drift
90d Mean
C$0.02
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.02 | C$0.01 – C$0.02 |
| 60 trading days | C$0.02 | C$0.01 – C$0.03 |
| 90 trading days | C$0.02 | C$0.01 – C$0.04 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Appili Therapeutics Inc
Appili Therapeutics Inc., a biopharmaceutical company, focuses on the acquisition and development of treatments targeting unmet needs in infectious diseases in the United States and Canada. The company offers LIKMEZ (ATI-1501), a liquid oral taste-masked reformulation of the antibiotic metronidazole to treat anaerobic bacterial and protozoal infections. It also develops ATI-1801, a topical formulation of paromomycin in a Phase III trial for the treatment of cutaneous leishmaniasis; and ATI-1701, a live-attenuated vaccine in preclinical trials for the prevention of Francisella tularensis infection. The company has a collaboration with Vitalex Biosciences to advance VXV-01, a dual-antigen vaccine targeting invasive Candida infections. Appili Therapeutics Inc. was incorporated in 2015 and is headquartered in Halifax, Canada.
Financials
- Revenue (TTM)
- $244,179
- EBITDA
- $-6.52M
- Profit Margin
- 0.00%
- ROE (TTM)
- -938.72%
- EPS (Diluted)
- -0.03
- Book Value
- -0.13
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
Advertisement
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Common Questions About APLI
Articles Featuring APLI.TO
Latest articles and analysis covering APLI.TO
Why Appili Therapeutics Inc stock is plummeting today
Appili Therapeutics Inc stock is down 33.33% today, closing at CA$0.01, raising concerns about its future viability in the market.
What's Going On With Appili Therapeutics Inc Stock Monday?
Appili Therapeutics Inc remains at a crucial juncture as it reports its fiscal year results and navigates through significant funding opportunities. The company’s stock has shown no movement recently, indicating investor uncertainty about its future.
What's Going On With Appili Therapeutics Inc Stock Monday?
Appili Therapeutics Inc has maintained its stock price at C$0.01 this week, with no significant news to drive movement. Investors are evaluating the company's financial health amid challenging conditions in the health care sector.
Why Appili Therapeutics Inc stock is plummeting today
Appili Therapeutics Inc's stock has plummeted by 33.33%, closing at CA$0.01. This drastic decline raises concerns about the company's future and financial stability.
Why Appili Therapeutics Inc stock is plummeting today
Appili Therapeutics Inc's stock has plummeted by 33.33% today, closing at CA$0.01. This steep decline raises questions about the company's financial health amidst a lack of significant news.
